Evidence map›Paper›PMID 36428650›Full record

ArticleCancers2022

Comorbidities and Risk Factors of Patients Diagnosed with CRC after Positive Fecal Test in Real Life.

Naim Abu-Freha, Rachel Gouldner, Bracha Cohen, Michal Gordon, Orly Sagi, Gadeer Taha, Liza Ben Shoshan, Zohar Levi

Abstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Naim Abu-FrehaThe Institute of Gastroenterology and Hepatology, Soroka University Medical Center, Beer-Sheva 84105, Israel.ORCID 0000-0002-4844-3308
Rachel GouldnerMedical School for International Health, Ben-Gurion University of the Negev, Beer-Sheva 84101, Israel.ORCID 0000-0002-6945-273X
Bracha CohenSoroka Clinical Research Center, Soroka University Medical Center, Beer-Sheva 84101, Israel.
Michal GordonSoroka Clinical Research Center, Soroka University Medical Center, Beer-Sheva 84101, Israel.
Orly SagiBacteriology Laboratory, Soroka University Medical Center, Beer-Sheva 84101, Israel.
Gadeer TahaDepartment of Gastroenterology, Rambam Health Care Campus, Haifa 31096, Israel.
Liza Ben ShoshanThe Institute of Gastroenterology and Hepatology, Soroka University Medical Center, Beer-Sheva 84105, Israel.
Zohar LeviDepartment of Gastroenterology, Beilinson Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv 39100, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Fecal occult blood test (FOBT) is the modality of choice in most countries for colorectal cancer (CRC) screening. We aimed to investigate the risk factors for CRC among patients with a positive FOBT in real life. (2) Methods: This was a retrospective study that included patients who tested positive for FOBT. Data regarding the comorbidities and laboratories were collected and compared between CRC and non-CRC groups. (3) Results: Positive FOBT was found among 45,500 (5.36%) subjects and CRC was found in 1502 (3.3%). CRC patients were older, age 62.7 ± 7.15 years compared with 59.33 ± 7.3 years (p < 0.001), and had significantly higher rates of hypertension (48.4% vs. 44.7%, p = 0.002), iron-deficiency anemia (20.6% vs. 16.4, p < 0.001), family history of CRC (7.3% vs. 5.1%, p < 0.001), and previous CRC (6.5% vs. 0.3%, p < 0.001). Lower levels of hemoglobin, iron, and ferritin were found in the CRC group. Age, family history of CRC, and previous CRC were found to be significant risk factors for diagnosis of CRC after positive FOBT with OR of 1.057, 1.4, and 15.9, respectively. (4) Conclusions: Iron-deficiency anemia, family history of CRC, previous colorectal cancer, and low hemoglobin, iron, and ferritin levels should direct physicians to give high priority to colonoscopy scheduling.

Indexed as

colorectal cancerfecal testingrisk factorscreening

Identifiers

PMID36428650
PMCPMC9688580

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.